Skip to Content

WPI 1118 (Mirtazapine 30 mg)

This pill with imprint "WPI 1118" is Yellow, Elliptical / Oval and has been identified as Mirtazapine 30 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; hot flashes; depression (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 1118

Mirtazapine

Imprint:
WPI 1118
Strength:
30 mg
Color:
Yellow
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide